12:00 AM
 | 
Jun 06, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Neurology
Alzheimer's disease (AD) Peripheral benzodiazepine receptor (TSPO;...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >